These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 18856026)

  • 21. Long lasting immunity in chickens induced by a single shot of influenza vaccine prepared from inactivated non-pathogenic H5N1 virus particles against challenge with a highly pathogenic avian influenza virus.
    Sasaki T; Kokumai N; Ohgitani T; Sakamoto R; Takikawa N; Lin Z; Okamatsu M; Sakoda Y; Kida H
    Vaccine; 2009 Aug; 27(38):5174-7. PubMed ID: 19596414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GSK's novel split-virus adjuvanted vaccines for the prevention of the H5N1 strain of avian influenza infection.
    Jones T
    Curr Opin Mol Ther; 2009 Jun; 11(3):337-45. PubMed ID: 19479667
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A universal epitope-based influenza vaccine and its efficacy against H5N1.
    Adar Y; Singer Y; Levi R; Tzehoval E; Perk S; Banet-Noach C; Nagar S; Arnon R; Ben-Yedidia T
    Vaccine; 2009 Mar; 27(15):2099-107. PubMed ID: 19356612
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of vaccines against influenza A virus (H5N1).
    Li WC; Huang YC
    Chang Gung Med J; 2007; 30(4):294-304. PubMed ID: 17939259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pandemic flu vaccine: are we doing enough?
    Campbell JD
    Clin Pharmacol Ther; 2007 Dec; 82(6):633-5. PubMed ID: 17998908
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pre- or post-pandemic influenza vaccine?
    Osterhaus AD
    Vaccine; 2007 Jun; 25(27):4983-4. PubMed ID: 17555851
    [No Abstract]   [Full Text] [Related]  

  • 27. Emulsion-based adjuvants for influenza vaccines.
    Vogel FR; Caillet C; Kusters IC; Haensler J
    Expert Rev Vaccines; 2009 Apr; 8(4):483-92. PubMed ID: 19348563
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Avian and pandemic influenza: an overview.
    Poland GA; Jacobson RM; Targonski PV
    Vaccine; 2007 Apr; 25(16):3057-61. PubMed ID: 17289227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Highly pathogenic H5N1 avian influenza virus: cause of the next pandemic?
    Pappaioanou M
    Comp Immunol Microbiol Infect Dis; 2009 Jul; 32(4):287-300. PubMed ID: 19318178
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vaccine shortage for pandemic influenza: can it be solved?
    López RA; Zorzopulos J
    Vaccine; 2006 Apr; 24(15):2701. PubMed ID: 16497415
    [No Abstract]   [Full Text] [Related]  

  • 31. Acceptance of a pandemic avian influenza vaccine in pregnancy.
    Beigi RH; Switzer GE; Meyn LA
    J Reprod Med; 2009 Jun; 54(6):341-6. PubMed ID: 19639922
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaccine preparedness--are we ready for the next influenza pandemic?
    Wright PF
    N Engl J Med; 2008 Jun; 358(24):2540-3. PubMed ID: 18550873
    [No Abstract]   [Full Text] [Related]  

  • 33. Vaccine production capacity for seasonal and pandemic (H1N1) 2009 influenza.
    Collin N; de Radiguès X;
    Vaccine; 2009 Aug; 27(38):5184-6. PubMed ID: 19563891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preclinical evaluation of a modified vaccinia virus Ankara (MVA)-based vaccine against influenza A/H5N1 viruses.
    Kreijtz JH; Suezer Y; de Mutsert G; van den Brand JM; van Amerongen G; Schnierle BS; Kuiken T; Fouchier RA; Löwer J; Osterhaus AD; Sutter G; Rimmelzwaan GF
    Vaccine; 2009 Oct; 27(45):6296-9. PubMed ID: 19840663
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protection of chickens against H5N1 highly pathogenic avian influenza virus infection by live vaccination with infectious laryngotracheitis virus recombinants expressing H5 hemagglutinin and N1 neuraminidase.
    Pavlova SP; Veits J; Keil GM; Mettenleiter TC; Fuchs W
    Vaccine; 2009 Jan; 27(5):773-85. PubMed ID: 19041677
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Influenza vaccine: globalization of public health stakes].
    Collin N; Briand S
    Med Trop (Mars); 2009 Aug; 69(4):322. PubMed ID: 19725377
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative efficacy of North American and antigenically matched reverse genetics derived H5N9 DIVA marker vaccines against highly pathogenic Asian H5N1 avian influenza viruses in chickens.
    Jadhao SJ; Lee CW; Sylte M; Suarez DL
    Vaccine; 2009 Oct; 27(44):6247-60. PubMed ID: 19686695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Animal models for the preclinical evaluation of candidate influenza vaccines.
    Bodewes R; Rimmelzwaan GF; Osterhaus AD
    Expert Rev Vaccines; 2010 Jan; 9(1):59-72. PubMed ID: 20021306
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plant-derived hemagglutinin protects ferrets against challenge infection with the A/Indonesia/05/05 strain of avian influenza.
    Shoji Y; Bi H; Musiychuk K; Rhee A; Horsey A; Roy G; Green B; Shamloul M; Farrance CE; Taggart B; Mytle N; Ugulava N; Rabindran S; Mett V; Chichester JA; Yusibov V
    Vaccine; 2009 Feb; 27(7):1087-92. PubMed ID: 19100806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety, immunogenicity and efficacy of poxvirus-based vector vaccines expressing the haemagglutinin gene of a highly pathogenic H5N1 avian influenza virus in pigs.
    Kyriakis CS; De Vleeschauwer A; Barbé F; Bublot M; Van Reeth K
    Vaccine; 2009 Apr; 27(16):2258-64. PubMed ID: 19428840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.